|
US6727230B1
(en)
*
|
1994-03-25 |
2004-04-27 |
Coley Pharmaceutical Group, Inc. |
Immune stimulation by phosphorothioate oligonucleotide analogs
|
|
US7935675B1
(en)
|
1994-07-15 |
2011-05-03 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6239116B1
(en)
*
|
1994-07-15 |
2001-05-29 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
US6429199B1
(en)
*
|
1994-07-15 |
2002-08-06 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules for activating dendritic cells
|
|
US20030026782A1
(en)
*
|
1995-02-07 |
2003-02-06 |
Arthur M. Krieg |
Immunomodulatory oligonucleotides
|
|
US6207646B1
(en)
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
|
EP0855184A1
(en)
*
|
1997-01-23 |
1998-07-29 |
Grayson B. Dr. Lipford |
Pharmaceutical composition comprising a polynucleotide and an antigen especially for vaccination
|
|
US6406705B1
(en)
*
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
|
US6218371B1
(en)
*
|
1998-04-03 |
2001-04-17 |
University Of Iowa Research Foundation |
Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
|
|
AU760795B2
(en)
*
|
1998-05-14 |
2003-05-22 |
Coley Pharmaceutical Gmbh |
Methods for regulating hematopoiesis using CpG-oligonucleotides
|
|
DK1077722T3
(da)
|
1998-05-22 |
2006-11-27 |
Ottawa Health Research Inst |
Fremgangsmåder og produkter til induktion af mukosaimmunitet
|
|
US6693086B1
(en)
*
|
1998-06-25 |
2004-02-17 |
National Jewish Medical And Research Center |
Systemic immune activation method using nucleic acid-lipid complexes
|
|
US20030022854A1
(en)
|
1998-06-25 |
2003-01-30 |
Dow Steven W. |
Vaccines using nucleic acid-lipid complexes
|
|
DE60044236D1
(de)
*
|
1999-02-17 |
2010-06-02 |
Csl Ltd |
Immunogene komplexe und methoden in bezug auf diese
|
|
US6949520B1
(en)
*
|
1999-09-27 |
2005-09-27 |
Coley Pharmaceutical Group, Inc. |
Methods related to immunostimulatory nucleic acid-induced interferon
|
|
DE60039715D1
(de)
*
|
1999-11-19 |
2008-09-11 |
Csl Ltd |
Hcv-impfstoff zusammensetzungen
|
|
US7585847B2
(en)
|
2000-02-03 |
2009-09-08 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory nucleic acids for the treatment of asthma and allergy
|
|
US20040131628A1
(en)
*
|
2000-03-08 |
2004-07-08 |
Bratzler Robert L. |
Nucleic acids for the treatment of disorders associated with microorganisms
|
|
EP1296714B1
(en)
*
|
2000-06-22 |
2009-08-26 |
University Of Iowa Research Foundation |
Combination of CpG and antibodies directed against CD19,CD20, CD22 or CD40 for the treatment or prevention of cancer.
|
|
KR100917101B1
(ko)
*
|
2000-08-04 |
2009-09-15 |
도요 보세키 가부시키가이샤 |
플렉시블 금속적층체 및 그 제조방법
|
|
EP1366077B1
(en)
*
|
2000-09-15 |
2011-05-25 |
Coley Pharmaceutical GmbH |
PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
|
|
WO2002069369A2
(en)
*
|
2000-12-08 |
2002-09-06 |
Coley Pharmaceutical Gmbh |
Cpg-like nucleic acids and methods of use thereof
|
|
EA007232B1
(ru)
|
2001-08-17 |
2006-08-25 |
Коли Фармасьютикал Гмбх |
Иммуностимулирующие олигонуклеотиды, содержащие комбинацию мотивов и обладающие повышенной активностью
|
|
US20060210555A1
(en)
*
|
2001-12-21 |
2006-09-21 |
Antigenics, Inc. |
Compositions comprising immunoreactive reagents and saponins, and methods of use thereof
|
|
NZ535952A
(en)
|
2002-04-04 |
2009-01-31 |
Coley Pharm Gmbh |
Immunostimulatory G,U-containing oligoribonucleotides
|
|
US20040053880A1
(en)
|
2002-07-03 |
2004-03-18 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
|
US7605138B2
(en)
|
2002-07-03 |
2009-10-20 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
|
US7576066B2
(en)
*
|
2002-07-03 |
2009-08-18 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
|
US7807803B2
(en)
|
2002-07-03 |
2010-10-05 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
|
US7569553B2
(en)
|
2002-07-03 |
2009-08-04 |
Coley Pharmaceutical Group, Inc. |
Nucleic acid compositions for stimulating immune responses
|
|
AR040996A1
(es)
|
2002-08-19 |
2005-04-27 |
Coley Pharm Group Inc |
Acidos nucleicos inmunoestimuladores
|
|
NZ540098A
(en)
|
2002-10-29 |
2008-09-26 |
Coley Pharmaceutical Group Ltd |
Use of CPG oligonucleotides in the treatment of hepatitis C virus infection
|
|
US7956043B2
(en)
|
2002-12-11 |
2011-06-07 |
Coley Pharmaceutical Group, Inc. |
5′ CpG nucleic acids and methods of use
|
|
EP1608403A2
(en)
*
|
2003-04-02 |
2005-12-28 |
Coley Pharmaceutical Group, Ltd. |
Immunostimulatory nucleic acid oil-in-water formulations for topical application
|
|
US7410975B2
(en)
*
|
2003-06-20 |
2008-08-12 |
Coley Pharmaceutical Group, Inc. |
Small molecule toll-like receptor (TLR) antagonists
|
|
US20050013812A1
(en)
*
|
2003-07-14 |
2005-01-20 |
Dow Steven W. |
Vaccines using pattern recognition receptor-ligand:lipid complexes
|
|
JP4989225B2
(ja)
*
|
2003-09-25 |
2012-08-01 |
コーリー ファーマシューティカル グループ，インコーポレイテッド |
核酸親油性接合体
|
|
NZ546275A
(en)
|
2003-10-30 |
2009-05-31 |
Coley Pharm Gmbh |
C-class oligonucleotides analogs with enhanced immunostimulatory potency
|
|
US20050239733A1
(en)
*
|
2003-10-31 |
2005-10-27 |
Coley Pharmaceutical Gmbh |
Sequence requirements for inhibitory oligonucleotides
|
|
JP2007526253A
(ja)
*
|
2004-02-19 |
2007-09-13 |
コーリー ファーマシューティカル グループ，インコーポレイテッド |
免疫刺激性ウイルスｒｎａオリゴヌクレオチド
|
|
US8076352B2
(en)
*
|
2004-03-15 |
2011-12-13 |
Ptc Therapeutics, Inc. |
Administration of carboline derivatives useful in the treatment of cancer and other diseases
|
|
US7767689B2
(en)
*
|
2004-03-15 |
2010-08-03 |
Ptc Therapeutics, Inc. |
Carboline derivatives useful in the treatment of cancer
|
|
US7601840B2
(en)
*
|
2004-03-15 |
2009-10-13 |
Ptc Therapeutics, Inc. |
Carboline derivatives useful in the inhibition of angiogenesis
|
|
US8076353B2
(en)
*
|
2004-03-15 |
2011-12-13 |
Ptc Therapeutics, Inc. |
Inhibition of VEGF translation
|
|
JP2008506789A
(ja)
*
|
2004-07-18 |
2008-03-06 |
シーエスエル、リミテッド |
インターフェロン−ガンマ応答強化を誘発するための免疫刺激複合体及びオリゴヌクレオチド処方物
|
|
US20070190072A1
(en)
*
|
2004-09-30 |
2007-08-16 |
Csl Limited Ludwig Institute For Cancer Research |
In vivo efficacy of ny-eso-1 plus adjuvant
|
|
MY159370A
(en)
*
|
2004-10-20 |
2016-12-30 |
Coley Pharm Group Inc |
Semi-soft-class immunostimulatory oligonucleotides
|
|
WO2006091915A2
(en)
*
|
2005-02-24 |
2006-08-31 |
Coley Pharmaceutical Group, Inc. |
Immunostimulatory oligonucleotides
|
|
EP1874325A2
(en)
*
|
2005-04-08 |
2008-01-09 |
Coley Pharmaceutical Group, Inc. |
Methods for treating infectious disease exacerbated asthma
|
|
AU2006241149A1
(en)
*
|
2005-04-26 |
2006-11-02 |
Coley Pharmaceutical Gmbh |
Modified oligoribonucleotide analogs with enhanced immunostimulatory activity
|
|
WO2007008463A2
(en)
*
|
2005-07-07 |
2007-01-18 |
Coley Pharmaceutical Group, Inc. |
Anti-ctla-4 antibody and cpg-motif-containing synthetic oligodeoxynucleotide combination therapy for cancer treatment
|
|
US20080233105A1
(en)
*
|
2005-09-13 |
2008-09-25 |
Green William R |
Compositions and methods for preventing or treating a viral infection
|
|
US20090214578A1
(en)
*
|
2005-09-16 |
2009-08-27 |
Coley Pharmaceutical Gmbh |
Immunostimulatory Single-Stranded Ribonucleic Acid with Phosphodiester Backbone
|
|
KR20080047463A
(ko)
*
|
2005-09-16 |
2008-05-28 |
콜리 파마슈티칼 게엠베하 |
뉴클레오티드 변형에 의한 짧은 간섭 리보핵산(ｓｉｒｎａ)의 면역자극 특성의 조절
|
|
WO2007050584A2
(en)
*
|
2005-10-24 |
2007-05-03 |
Discoverx, Inc. |
Detection of intracellular enzyme complex
|
|
WO2007062107A2
(en)
|
2005-11-25 |
2007-05-31 |
Coley Pharmaceutical Gmbh |
Immunostimulatory oligoribonucleotides
|
|
WO2007095316A2
(en)
*
|
2006-02-15 |
2007-08-23 |
Coley Pharmaceutical Gmbh |
Compositions and methods for oligonucleotide formulations
|
|
US20100226920A1
(en)
*
|
2006-03-27 |
2010-09-09 |
Ablynx N.V. |
Medical delivery device for therapeutic proteins based on single domain antibodies
|
|
MX2009003398A
(es)
|
2006-09-27 |
2009-08-12 |
Coley Pharm Gmbh |
Analogos de oligonucleotidos cpg que contienen analogos t hidrofobos con actividad inmunoestimuladora mejorada.
|
|
US20090142362A1
(en)
*
|
2006-11-06 |
2009-06-04 |
Avant Immunotherapeutics, Inc. |
Peptide-based vaccine compositions to endogenous cholesteryl ester transfer protein (CETP)
|
|
FR2920024B1
(fr)
*
|
2007-08-14 |
2012-12-14 |
Lfb Biotechnologies |
Procede de purification ou de detection d'une proteine cible
|
|
JP2010536907A
(ja)
|
2007-08-31 |
2010-12-02 |
ニューリミューン セラピューティクス エイジー |
患者にアミロイドーシスおよびタンパク質凝集性障害における特異的免疫応答をもたらす方法
|
|
US20100040576A1
(en)
*
|
2007-12-18 |
2010-02-18 |
The Texas A&M University System |
Modified Oligonucleotides For The Treatment Of Hepatitis C Infection
|
|
WO2009105641A2
(en)
*
|
2008-02-20 |
2009-08-27 |
New York University |
Preventing and treating amyloid-beta deposition by stimulation of innate immunity
|
|
TWI351288B
(en)
*
|
2008-07-04 |
2011-11-01 |
Univ Nat Pingtung Sci & Tech |
Cpg dna adjuvant in avian vaccines
|
|
WO2010023216A1
(en)
*
|
2008-08-28 |
2010-03-04 |
Glaxosmithkline Biologicals S.A. |
Vaccine
|
|
KR101329374B1
(ko)
|
2008-12-09 |
2013-11-14 |
콜레이 파마시티컬 그룹, 인코포레이티드 |
면역자극성 올리고뉴클레오타이드
|
|
BRPI0922561A2
(pt)
|
2008-12-09 |
2020-08-11 |
Pfizer Vaccines Llc |
vacina de peptídeo de ch3 da ige.
|
|
KR101856462B1
(ko)
|
2009-03-25 |
2018-05-10 |
보드 오브 리전츠, 더 유니버시티 오브 텍사스 시스템 |
병원체에 대한 포유동물의 선천성 면역 저항성의 자극을 위한 조성물
|
|
DK2424562T3
(en)
|
2009-04-30 |
2015-12-07 |
Coley Pharm Group Inc |
Pneumococcal vaccine and uses thereof
|
|
WO2010138652A1
(en)
|
2009-05-27 |
2010-12-02 |
Ptc Therapeutics, Inc. |
Methods for treating kaposi sarcoma
|
|
HUE052510T2
(hu)
*
|
2009-05-27 |
2021-05-28 |
Ptc Therapeutics Inc |
Módszerek a rák és a nem daganatos állapotok kezelésére
|
|
WO2010138685A1
(en)
|
2009-05-27 |
2010-12-02 |
Ptc Therapeutics, Inc. |
Methods for treating prostate conditions
|
|
CN102596236B
(zh)
|
2009-07-30 |
2015-06-24 |
辉瑞疫苗有限责任公司 |
抗原性Tau肽及其用途
|
|
KR101660578B1
(ko)
|
2009-09-03 |
2016-09-27 |
화이자 백신스 엘엘씨 |
Ｐｃｓｋ９ 백신
|
|
SG181628A1
(en)
|
2009-12-22 |
2012-07-30 |
Celldex Therapeutics Inc |
Vaccine compositions
|
|
WO2011097384A2
(en)
*
|
2010-02-04 |
2011-08-11 |
Board Of Regents, The University Of Texas System |
Tumor targeted delivery of immunomodulators by nanoplymers
|
|
US20130012916A1
(en)
|
2010-02-11 |
2013-01-10 |
Glide Pharmaceutical Technologies Limited |
Delivery of immunoglobulin variable domains and constructs thereof
|
|
HRP20181039T1
(hr)
*
|
2010-05-28 |
2018-08-24 |
Zoetis Belgium S.A. |
Cjepiva koja sadrže kolesterol i cpg kao jedine molekule koje nose adjuvans
|
|
CA2798837A1
(en)
|
2010-06-07 |
2011-12-15 |
Pfizer Inc. |
Her-2 peptides and vaccines
|
|
EP2575868A1
(en)
|
2010-06-07 |
2013-04-10 |
Pfizer Vaccines LLC |
Ige ch3 peptide vaccine
|
|
WO2011161263A1
(en)
|
2010-06-25 |
2011-12-29 |
Ablynx Nv |
Pharmaceutical compositions for cutaneous administration
|
|
WO2012131504A1
(en)
|
2011-03-02 |
2012-10-04 |
Pfizer Inc. |
Pcsk9 vaccine
|
|
US9505847B2
(en)
|
2011-08-22 |
2016-11-29 |
Cnj Holdings Inc |
Clostridium difficile antibodies
|
|
EP2659908A1
(en)
|
2012-05-01 |
2013-11-06 |
Affiris AG |
Compositions
|
|
EP2659906A1
(en)
|
2012-05-01 |
2013-11-06 |
Affiris AG |
Compositions
|
|
EP2659907A1
(en)
|
2012-05-01 |
2013-11-06 |
Affiris AG |
Compositions
|
|
CN112587671A
(zh)
*
|
2012-07-18 |
2021-04-02 |
博笛生物科技有限公司 |
癌症的靶向免疫治疗
|
|
WO2014186623A2
(en)
*
|
2013-05-17 |
2014-11-20 |
Biomed Valley Discoveries |
Methods and compositions for the treatment of a chagas disease
|
|
EP3046588B1
(en)
|
2013-09-17 |
2022-03-02 |
OBI Pharma, Inc. |
Compositions of a carbohydrate vaccine for inducing immune responses and uses thereof in cancer treatment
|
|
CN104861063A
(zh)
*
|
2014-01-10 |
2015-08-26 |
博笛生物科技有限公司 |
靶向her2阳性肿瘤的化合物和组合物
|
|
CN104861064A
(zh)
*
|
2014-01-10 |
2015-08-26 |
博笛生物科技有限公司 |
靶向表达egfr的肿瘤的化合物和组合物
|
|
EP3092256B1
(en)
*
|
2014-01-10 |
2022-05-18 |
Birdie Biopharmaceuticals Inc. |
Compounds and compositions for immunotherapy
|
|
US11160855B2
(en)
|
2014-01-21 |
2021-11-02 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens and uses thereof
|
|
IL312327B2
(en)
|
2014-01-21 |
2026-02-01 |
Pfizer |
Immunogenic preparations comprising conjugated capsular saccharide antigens and their uses
|
|
EP3104877B1
(en)
|
2014-02-11 |
2020-01-22 |
The USA, as represented by The Secretary, Department of Health and Human Services |
Pcsk9 vaccine and methods of using the same
|
|
SG10201806481XA
(en)
|
2014-02-19 |
2018-09-27 |
Emergent Biosolutions Canada Inc |
Marburg monoclonal antibodies
|
|
ES2772817T3
(es)
|
2014-04-10 |
2020-07-08 |
Obi Pharma Inc |
Anticuerpos de unión a antígenos de carbohidrato asociados a tumor, composiciones farmacéuticas y sus usos
|
|
DK4001311T3
(da)
|
2014-07-09 |
2026-02-02 |
Birdie Biopharmaceuticals Inc |
Anti-pd-l1/pd-1-kombinationer til behandling af tumorer
|
|
CN112546238A
(zh)
*
|
2014-09-01 |
2021-03-26 |
博笛生物科技有限公司 |
用于治疗肿瘤的抗-pd-l1结合物
|
|
WO2016040344A1
(en)
*
|
2014-09-08 |
2016-03-17 |
Perkins Biosystems, Llc |
Innate immune modulating molecule complex for the activation of the innate immune system of aquatic animals and methods therefor
|
|
WO2016044839A2
(en)
|
2014-09-19 |
2016-03-24 |
The Board Of Regents Of The University Of Texas System |
Compositions and methods for treating viral infections through stimulated innate immunity in combination with antiviral compounds
|
|
PL3244917T3
(pl)
|
2015-01-15 |
2023-07-17 |
Pfizer Inc. |
Kompozycje immunogenne do zastosowania w szczepionkach przeciwko pneumokokom
|
|
CN107427514B
(zh)
|
2015-03-16 |
2021-07-13 |
豪夫迈·罗氏有限公司 |
使用tlr7激动剂和hbv衣壳装配抑制剂的组合治疗
|
|
CA2986494A1
(en)
|
2015-06-03 |
2016-12-08 |
Affiris Ag |
Il-23-p19 vaccines
|
|
EP3319988A1
(en)
|
2015-07-07 |
2018-05-16 |
Affiris AG |
Vaccines for the treatment and prevention of ige mediated diseases
|
|
KR20250058066A
(ko)
|
2015-07-21 |
2025-04-29 |
화이자 인코포레이티드 |
접합된 캡슐형 사카라이드 항원을 포함하는 면역원성 조성물, 그를 포함하는 키트 및 그의 용도
|
|
EP3344806A4
(en)
|
2015-09-04 |
2019-03-20 |
OBI Pharma, Inc. |
GLYCANARRAYS AND METHOD OF USE
|
|
WO2017040932A1
(en)
|
2015-09-04 |
2017-03-09 |
Primatope Therapeutics Inc. |
Humanized anti-cd40 antibodies and uses thereof
|
|
CR20180229A
(es)
|
2015-10-29 |
2018-08-24 |
Novartis Ag |
Conjugados de anticuerpos que comprenden un agonista del receptor tipo toll
|
|
US10786561B2
(en)
|
2015-11-20 |
2020-09-29 |
Pfizer Inc. |
Immunogenic compositions for use in pneumococcal vaccines
|
|
CN106943596A
(zh)
|
2016-01-07 |
2017-07-14 |
博笛生物科技（北京）有限公司 |
用于治疗肿瘤的抗-cd20组合
|
|
CN106943598A
(zh)
|
2016-01-07 |
2017-07-14 |
博笛生物科技（北京）有限公司 |
用于治疗肿瘤的抗-her2组合
|
|
CN106943597A
(zh)
|
2016-01-07 |
2017-07-14 |
博笛生物科技（北京）有限公司 |
用于治疗肿瘤的抗-egfr组合
|
|
AU2017239637A1
(en)
|
2016-03-29 |
2018-11-15 |
Obi Pharma, Inc. |
Antibodies, pharmaceutical compositions and methods
|
|
US10980894B2
(en)
|
2016-03-29 |
2021-04-20 |
Obi Pharma, Inc. |
Antibodies, pharmaceutical compositions and methods
|
|
IL262296B2
(en)
|
2016-04-22 |
2024-09-01 |
Obi Pharma Inc |
Cancer immunotherapy by immune activation or immune modulation via globo series antigens
|
|
KR20190067765A
(ko)
|
2016-07-27 |
2019-06-17 |
오비아이 파머 인코퍼레이티드 |
면역원성/치료 글리칸 조성물 및 그의 용도
|
|
KR102528998B1
(ko)
|
2016-07-29 |
2023-05-03 |
오비아이 파머 인코퍼레이티드 |
인간 항체, 제약 조성물 및 방법
|
|
WO2018094414A1
(en)
|
2016-11-21 |
2018-05-24 |
Obi Pharma, Inc. |
Conjugated biological molecules, pharmaceutical compositions and methods
|
|
BR112019014833A2
(pt)
|
2017-01-20 |
2020-04-14 |
Pfizer |
composições imunogênicas para uso em vacinas pneumococais
|
|
CN108794467A
(zh)
|
2017-04-27 |
2018-11-13 |
博笛生物科技有限公司 |
2-氨基-喹啉衍生物
|
|
FI3641771T3
(fi)
|
2017-06-23 |
2026-08-11 |
Birdie Biopharmaceuticals Inc |
Farmaseuttisia koostumuksia
|
|
US11458126B2
(en)
|
2017-08-01 |
2022-10-04 |
Ptc Therapeutics, Inc. |
DHODH inhibitor for use in treating hematologic cancers
|
|
US12247052B2
(en)
*
|
2018-03-02 |
2025-03-11 |
Elicio Therapeutics, Inc. |
CpG amphiphiles and uses thereof
|
|
US11633471B2
(en)
|
2018-03-06 |
2023-04-25 |
Unm Rainforest Innovations |
Compositions and methods for reducing serum triglycerides
|
|
TW202504930A
(zh)
|
2018-06-27 |
2025-02-01 |
台灣浩鼎生技股份有限公司 |
用於糖蛋白工程的糖苷合成酶變體及其使用方法
|
|
US11260119B2
(en)
|
2018-08-24 |
2022-03-01 |
Pfizer Inc. |
Escherichia coli compositions and methods thereof
|
|
US20220016229A1
(en)
|
2018-12-12 |
2022-01-20 |
Pfizer Inc. |
Immunogenic Multiple Hetero-Antigen Polysaccharide-Protein Conjugates and uses thereof
|
|
US20220184199A1
(en)
|
2019-04-10 |
2022-06-16 |
Pfizer Inc. |
Immunogenic compositions comprising conjugated capsular saccharide antigens, kits comprising the same and uses thereof
|
|
AU2020375214B2
(en)
|
2019-11-01 |
2024-02-08 |
Pfizer Inc. |
Escherichia coli compositions and methods thereof
|
|
KR20220143910A
(ko)
|
2020-02-23 |
2022-10-25 |
화이자 인코포레이티드 |
에스케리키아 콜라이 조성물 및 그의 방법
|
|
US12138302B2
(en)
|
2020-10-27 |
2024-11-12 |
Pfizer Inc. |
Escherichia coli compositions and methods thereof
|
|
MX2023004912A
(es)
|
2020-10-27 |
2023-05-16 |
Pfizer |
Composiciones de escherichia coli y metodos de las mismas.
|
|
CA3200602A1
(en)
|
2020-11-04 |
2022-05-12 |
Pfizer Inc. |
Immunogenic compositions for use in pneumococcal vaccines
|
|
US12357681B2
(en)
|
2020-12-23 |
2025-07-15 |
Pfizer Inc. |
E. coli FimH mutants and uses thereof
|
|
WO2022147373A1
(en)
|
2020-12-31 |
2022-07-07 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Antibody-guided pcsk9-mimicking immunogens lacking 9-residue sequence overlap with human proteins
|
|
TW202602467A
(zh)
|
2024-03-11 |
2026-01-16 |
美商輝瑞股份有限公司 |
包含經共軛之大腸桿菌糖的免疫原性組成物及其用途
|